These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 13934500)

  • 21. [POSSIBILITIES OF ORAL DIABETES THERAPY].
    MEHNERT H; MAHRHOFER E; KAISER W
    Ther Ggw; 1964 Jan; 103():21-33. PubMed ID: 14127811
    [No Abstract]   [Full Text] [Related]  

  • 22. [EXPERIMENTAL BASIS FOR COMBINED TREATMENT OF DIABETES WITH THE BIGUANIDE-SULFONAMIDE ASSOCIATION].
    STERNE J; HIRSCH C
    Diabete; 1964; 12():171-5. PubMed ID: 14173920
    [No Abstract]   [Full Text] [Related]  

  • 23. LONG-TERM CHLORPROPAMIDE THERAPY IN DIABETES: FOUR YEARS' EXPERIENCE.
    EVANS JR; EVANS BR; EVANS GR
    J Am Geriatr Soc; 1964 Feb; 12():195-201. PubMed ID: 14118834
    [No Abstract]   [Full Text] [Related]  

  • 24. [ORAL THERAPY OF DIABETES MELLITUS WITH 2-BENZENESULFONAMIDO-5-(2-METHOXYETHOXY)-PYRIMIDINE (GLYCODIAZIN)].
    BERNHARD H
    Arzneimittelforschung; 1964 May; 14():411-2. PubMed ID: 14238602
    [No Abstract]   [Full Text] [Related]  

  • 25. [OUR EXPERIENCES WITH ORAL ANTIDIABETICS IN OUTPATIENT CONTROL AND TREATMENT OF DIABETIC PATIENTS].
    ANGELI I
    Orv Hetil; 1964 Nov; 105():2186-90. PubMed ID: 14216805
    [No Abstract]   [Full Text] [Related]  

  • 26. [THE THERAPY OF DIABETES MELLITUS].
    CAGLI V
    Policlinico Prat; 1964 Jan; 71():1-21. PubMed ID: 14126452
    [No Abstract]   [Full Text] [Related]  

  • 27. A quantum chemical study with special reference to the sulfamyl group of sulfonylureas.
    Orita Y; Ando A; Takamitsu Y; Urakabe S; Shirai D
    Jpn Circ J; 1970 Sep; 34(9):775-8. PubMed ID: 5537674
    [No Abstract]   [Full Text] [Related]  

  • 28. EXPERIMENTAL DIABETES AND THE MODE OF ACTION OF THE SULFONYLUREAS. WITH SOME SPECULATIONS ON THE PREVENTION OF DIABETES.
    FOA PP
    Bull Sinai Hosp Detroit; 1964; 12():31-46. PubMed ID: 14156394
    [No Abstract]   [Full Text] [Related]  

  • 29. Clinical trial of amino-methylbenzol-sulphonyl-cyclohexylurea (metahexamide) in diabetics after failure of tolbutamide.
    HUSKISSON ID; JACKSON WP
    S Afr Med J; 1960 Jan; 34():34-5. PubMed ID: 14405589
    [No Abstract]   [Full Text] [Related]  

  • 30. [2 CASES OF HEMIPLEGIA INDICATIVE OF SEVERE HYPOGLYCEMIA INDUCED BY HYPOGLYCEMIC SULFONAMIDES].
    HAZARD J; DOMART A
    Bull Mem Soc Med Hop Paris; 1965 Feb; 116():473-6. PubMed ID: 14308218
    [No Abstract]   [Full Text] [Related]  

  • 31. [THE INDICATIONS FOR USE AND THE EFFECTIVENESS OF SULFANILAMIDE PREPARATIONS IN DIABETES MELLITUS].
    GUSMAN SM; ALEKPEROV MA
    Sov Med; 1963 May; 26():13-8. PubMed ID: 14073318
    [No Abstract]   [Full Text] [Related]  

  • 32. [Thyroid gland function of patients with diabetes in long-term use of glibornuride].
    Reinwein D
    Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2221. PubMed ID: 4125093
    [No Abstract]   [Full Text] [Related]  

  • 33. [BIOPSY OF THE STOMACH IN THE DIABETIC TREATED WITH HYPOGLYCEMIC DRUGS. COMPARATIVE STUDY].
    PRESS L; LEMOSGARCIA M; ALVARINAS CE; BARONLIS E
    Rev Asoc Med Argent; 1964 Jun; 78():294-301. PubMed ID: 14177798
    [No Abstract]   [Full Text] [Related]  

  • 34. Effects of sulfonylurea compounds on hyperlipemia and hypercholesteremia in patients with minimal impairment of glucose tolerance.
    SHIPP JC; MUNROE JF
    Diabetes; 1962; 11(Suppl)():69-73. PubMed ID: 13977373
    [No Abstract]   [Full Text] [Related]  

  • 35. Clinical experiences with chlorpropamide, with special reference to comparison with previous experience with carbutamide and tolbutamide.
    HEINSEN HA
    Ann N Y Acad Sci; 1959 Mar; 74(3):709-16. PubMed ID: 13637612
    [No Abstract]   [Full Text] [Related]  

  • 36. In vitro effects of carbutamide and tolbutamide on isolated frog muscle.
    GOURLEY DR; DODD RH
    Am J Physiol; 1958 Mar; 192(3):471-5. PubMed ID: 13520936
    [No Abstract]   [Full Text] [Related]  

  • 37. [THE MECHANISM OF ACTION OF PERORAL ANTIDIABETICS].
    HORN Z
    Bull Schweiz Akad Med Wiss; 1965 Feb; 21():67-76. PubMed ID: 14256856
    [No Abstract]   [Full Text] [Related]  

  • 38. [Clinical experience with the blood sugar reducing sulfonamide derivative glisoxepide].
    Petzoldt R; Riedesel G; Ramrath M; Grabs V; Haupt E; Schwedes U; Ewald W; Beyer J; Schöffling K
    Arzneimittelforschung; 1974 Mar; 24(0):429-32. PubMed ID: 4603399
    [No Abstract]   [Full Text] [Related]  

  • 39. [Metabolic studies with oral hypoglycemic substances in diabetics].
    HAUK G; MARING H
    Arztl Wochensch; 1959 Sep; 14():731-5. PubMed ID: 13852085
    [No Abstract]   [Full Text] [Related]  

  • 40. [Behavior of the blood sugar and phosphorus levels during the glucose tolerance test before and after the administration of carbutamide, tolbutamide and chlorpropamide].
    GIULIANO G; COLAJANNI L
    Boll Soc Ital Biol Sper; 1959 Dec; 35():1977-80. PubMed ID: 13828262
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.